Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00374595 · ClinicalTrials.gov registry record
Vascular Risk After Kidney Transplantation
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 338
- Enrollment target
NCT00374595: Completed study, sponsored by University of Nebraska.
NCT00374595 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 338 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00374595 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 338 participants
- Enrollment target
Study Summary
Hypothesis: Nontraditional risk factors, such as inflammation, vitamin D deficiency, elevated PTH, insulin resistance, homocysteine, or uric acid, contribute to cardiovascular disease progression after kidney transplant. The purpose of this study is to evaluate which traditional and nontraditional cardiovascular disease risk factors best predict progression of cardiovascular disease (CVD) using carotid intima media thickness performed by ultrasound, in kidney transplant patients.
Primary Outcome
CIMT was defined by ultrasound. The mean and standard error of a 3 year change in CIMT was assessed (between baseline and three year follow up).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2006-04 |
| Est. Completion | 2023-06-20 |
What the finished NCT00374595 record still lists
NCT00374595 is an observational study that tracks outcomes without assigning an intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00374595 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00374595 about?
NCT00374595 is a clinical study titled "Vascular Risk After Kidney Transplantation". Hypothesis: Nontraditional risk factors, such as inflammation, vitamin D deficiency, elevated PTH, insulin resistance, homocysteine, or uric acid, contribute to cardiovascular disease progression after kidney transplant. The purpose of this study is to evaluate which traditional and nontraditional ...
What is the current status of trial NCT00374595?
This trial is currently completed. The enrollment target is 338 participants. The study started on 2006-04. Estimated completion is 2023-06-20.
Who is sponsoring clinical trial NCT00374595?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia